Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 02/07/2025 | CALL | $37.00 | 10,178 | +9,684 | +1,960.32% |
| 02/07/2025 | CALL | $40.50 | 9,273 | +8,905 | +2,419.84% |
| 12/18/2026 | PUT | $45.00 | 6,488 | +4,505 | +227.18% |
| 01/16/2026 | PUT | $35.00 | 12,462 | +1,358 | +12.23% |
| 02/07/2025 | CALL | $39.50 | 1,807 | +1,173 | +185.02% |
| 06/20/2025 | CALL | $40.00 | 3,360 | +1,037 | +44.64% |
| 03/21/2025 | PUT | $35.00 | 8,030 | -446 | -5.26% |
| 02/21/2025 | CALL | $38.00 | 425 | -462 | -52.09% |
| 02/07/2025 | CALL | $38.00 | 2,664 | -809 | -23.29% |
| 03/21/2025 | CALL | $50.00 | 25,675 | -1,100 | -4.11% |
| 01/16/2026 | CALL | $35.00 | 4,984 | -6,320 | -55.91% |
| 02/07/2025 | CALL | $44.50 | 9,101 | -9,000 | -49.72% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.57% | 9.93M | 1.25B |
| Vanguard International Growth Fund | 2.53% | 9.77M | 1.23B |
| Vanguard 500 Index Fund | 1.98% | 7.64M | 961.76M |
| Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 1.31% | 5.08M | 639.64M |
| Fidelity 500 Index Fund | 0.94% | 3.62M | 456.08M |
| SPDR S&P 500 ETF Trust | 0.92% | 3.57M | 449.61M |
| Vanguard Specialized-Health Care Fund | 0.90% | 3.49M | 439.87M |
| Growth Fund Of America Inc | 0.80% | 3.11M | 391.58M |
| iShares Core S&P 500 ETF | 0.76% | 2.95M | 371.32M |
| Vanguard U.S. Growth Fund | 0.75% | 2.88M | 362.55M |
Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock?
01/30 10:15 am
The Motley Fool
Read morePotential Revolution in Healthcare Brewing, Powered by AI Innovation
01/29 09:04 am
Benzinga
Read moreNetflix, Palantir And Moderna Are Among Top 12 Large Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio?
01/26 09:30 am
Benzinga
Read moreWhy Moderna Stock Jumped Over 20% This Week
01/25 04:11 pm
The Motley Fool
Read more3 Things You Need to Know if You Buy Moderna Today
01/25 11:30 am
The Motley Fool
Read moreTrump Sparks Records On Wall Street, AI Stargate Project Lifts Chipmakers; Inflation, Tariff Jitters Arise: This Week In The Market
01/24 05:31 pm
Benzinga
Read moreThese 3 Stocks Are Down to Start 2025. What's Going On?
01/22 12:34 pm
The Motley Fool
Read moreWhy Is Moderna Stock Trading Higher On Tuesday?
01/21 01:08 pm
Benzinga
Read moreWhere Will Moderna Be in 3 Years?
01/21 11:15 am
The Motley Fool
Read moreIf I Could Buy Only 1 ETF in 2025, This Would Be It
01/19 06:50 am
The Motley Fool
Read moreIs Moderna Stock a Buy?
01/19 05:55 am
The Motley Fool
Read moreModerna Dropped by 20% This Week -- Is It a Smart Buy Right Now?
01/16 03:47 pm
The Motley Fool
Read moreIs Moderna a Bad-News Buy for 2025?
01/16 09:10 am
The Motley Fool
Read moreIs Moderna Stock a No-Brainer Buy on the Sell-Off?
01/15 05:52 am
The Motley Fool
Read moreStocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday?
01/13 03:22 pm
Benzinga
Read moreWhy Moderna Stock Just Crashed 21%
01/13 12:46 pm
The Motley Fool
Read moreThis Top ETF Has Generated 1,400% Returns in 20 Years. Here's Why It Can Still Soar Even Higher.
01/12 05:50 am
The Motley Fool
Read moreStock Market Roundup 2024: Here's What Worked, What Didn't, and What Stocks Investors Can Buy Now and Hold Forever
01/11 06:01 am
The Motley Fool
Read morePrediction: These Could Be the Best-Performing Value Stocks Through 2030
01/08 06:48 am
The Motley Fool
Read moreInvestors Look Back at 2024
01/06 04:33 pm
The Motley Fool
Read moreIs Moderna Stock a Buy?
12/20 07:45 am
The Motley Fool
Read more3 Stocks That Could Turn $1,000 into $5,000 by 2030
12/20 05:50 am
The Motley Fool
Read more3 No-Brainer Biotech Stocks to Buy With $200 Right Now
12/18 06:44 am
The Motley Fool
Read moreNasdaq 100 Shakeup: 3 Stocks That Can Gain
12/16 04:27 pm
Investing.com
Read moreWhy I Can't Stop Buying This Ultra-High-Yielding ETF
12/16 05:51 am
The Motley Fool
Read moreThese Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over
12/12 08:03 am
The Motley Fool
Read moremRNA Therapeutics Market Size to Hit USD 48.65 Billion by 2032 due to Advances in Cancer Treatment and Expanding mRNA Vaccine Applications | Research by SNS Insider
12/08 09:00 am
GlobeNewswire Inc.
Read moreIs Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024?
12/05 07:45 am
The Motley Fool
Read moreThese Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
11/26 08:30 am
The Motley Fool
Read moreהיום הוא המועד לתביעה נגד MGX: רוזן, פירמת עורכי דין מהשורה הראשונה, מעודדת את משקיעי Metagenomi, Inc לקבל ייעוץ לפני התאריך החשוב היום 25 בנובמבר בתביעה ייצוגית בניירות ערך – MGX
11/25 02:50 pm
GlobeNewswire Inc.
Read moreתאריך היעד לתביעה נגד MGX ביום שני: רוזן, משרד עורכי דין מהשורה הראשונה, מעודד את המשקיעים ב- Metagenomi, Inc לקבל ייעוץ לפני תאריך יעד חשוב של 25 בנובמבר בתביעה ייצוגית בניירות ערך – MGX
11/22 03:40 pm
GlobeNewswire Inc.
Read moreDEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024
11/22 12:59 pm
GlobeNewswire Inc.
Read moreIs Biotech’s Bull Run Over? Examining Election Impacts
11/22 08:29 am
Investing.com
Read more1 High-Yield Dividend ETF to Buy to Generate Passive Income
11/09 05:33 am
The Motley Fool
Read moreDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
11/06 10:13 pm
GlobeNewswire Inc.
Read moreIs It Time to Buy October's Worst-Performing Nasdaq Stocks?
11/06 05:11 am
The Motley Fool
Read moreDEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Metagenomi to Contact Us to Have Their Losses Evaluated Today
11/02 08:32 am
GlobeNewswire Inc.
Read moreINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
10/30 09:09 pm
GlobeNewswire Inc.
Read moreGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)
10/28 04:50 pm
GlobeNewswire Inc.
Read moreROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX
10/27 08:22 am
GlobeNewswire Inc.
Read moreROSEN, A TOP-RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX
10/24 06:01 pm
GlobeNewswire Inc.
Read moreRLF, A TOP-RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX
10/21 04:54 pm
GlobeNewswire Inc.
Read moreThis Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
10/21 07:45 am
The Motley Fool
Read moreHow Bad Is This News for Novavax?
10/19 06:15 pm
The Motley Fool
Read more全國出庭法律顧問 RLF 鼓勵 Metagenomi, Inc. 投資者在證券集體訴訟的重要截止日期前聘請律師 – MGX
10/19 01:22 pm
GlobeNewswire Inc.
Read moreRLF, NATIONAL TRIAL COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX
10/18 05:56 pm
GlobeNewswire Inc.
Read moreMGX INVESTOR ALERT: Kirby McInerney LLP Reminds Metagenomi Inc. Investors of Deadline in Class Action Lawsuit
10/17 05:40 pm
GlobeNewswire Inc.
Read moreGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)
10/17 12:00 pm
GlobeNewswire Inc.
Read more